A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB)
Public ClinicalTrials.gov record NCT02138747. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Double-Blind, Randomized, Two-Period Crossover, Multi-Center Study to Evaluate the Tolerability and Patient Preference Between Myrbetriq® and Detrol® LA in Subjects With Overactive Bladder (OAB)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to assess tolerability of mirabegron compared to tolterodine ER in the treatment of participants with symptoms of Overactive Bladder (OAB) as well as the impact of treatment on micturition frequency and incontinence episodes.
Study identification
- NCT ID
- NCT02138747
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 376 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 24, 2014 (Actual)
- Primary completion
- Oct 29, 2015 (Actual)
- Completion
- Nov 11, 2015 (Actual)
- Last update posted
- Feb 26, 2020
2014 – 2015
United States locations
- U.S. sites
- 22
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site US10002 Urology Centers of Alabama | Homewood | Alabama | 35209 | — |
| Site US10004 Alaska Clinical Research Center, LLC | Anchorage | Alaska | 99503 | — |
| Site US10001 Urological Associates of Southern Arizona | Tucson | Arizona | 85715 | — |
| Site US10003 Genesis Research | San Diego | California | 92123 | — |
| Site US10010 Skyline Urology | Sherman Oaks | California | 91411 | — |
| Site US10028 Clinical Research Consulting | Milford | Connecticut | 06460 | — |
| Site US10024 Coastal Connecticut Research, LLC | New London | Connecticut | 06320 | — |
| Site US10033 Eastern Research | Hialeah | Florida | 33013 | — |
| Site US10023 Advanced Clinical Research of Miami | Miami | Florida | 33155 | — |
| Site US10007 Pinellas Urology, Inc | St. Petersburg | Florida | 33710 | — |
| Site US10022 Palm Beach Research Center | West Palm Beach | Florida | 33409 | — |
| Site US10008 The Iowa Clinic PC, Urology | West Des Moines | Iowa | 50266 | — |
| Site US10014 Mid Atlantic Clinical Research | Greenbelt | Maryland | 20770 | — |
| Site US10005 Boston Clinical Trials | Boston | Massachusetts | 02131 | — |
| Site US10021 AccuMed Research Associates | Garden City | New York | 11530-1664 | — |
| Site US10013 Advanced Urology Centers of New York | Plainview | New York | 11803 | — |
| Site US10020 Upstate Clinical Research Associates LLC | Williamsville | New York | 14221 | — |
| Site US10017 The Jackson Clinic | Jackson | Tennessee | 38305 | — |
| Site US10057 Practice Research Organization | Dallas | Texas | 75230 | — |
| Site US10035 Millennium Clinical Research Center | Arlington | Virginia | 22203 | — |
| Site US10032 Clinical Research and Consulting Center, LLC | Fairfax | Virginia | 22030 | — |
| Site US10034 Health Research of Hampton Roads Inc | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02138747, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 26, 2020 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02138747 live on ClinicalTrials.gov.